Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: P2C 8692 Principal Investigator: Adkins, Douglas
Title: A T1 Translational Multicenter Randomized Phase II Study of Temsirolimus versus Cetuximab Plus Temsirolimus in Patients with Recurrent / Metastatic Head and Neck Cancer, Who Failed Prior EGFR Based Therapy
Phase: II Disease Site: Multiple Sites
Participating Site(s):
 
Main Campus
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to learn if Temsirolimus (TORISEL®) alone or in combination with Cetuximab (ERBITUX®) can potentially have an effect on head and neck cancers in people who were previously treated with Cetuximab (or another agent in the same class [EGFR inhibitors]) but no longer benefit from this treatment.
 
More Information:
ClinicalTrials.gov #
Internal Protocol Documents (requires Siteman administrative database password)